← All companies

SCTX

Scribe Therapeutics Inc.

SCTX Biological Products, (No Diagnostic Substances) EDGAR ↗

$20.84

+1.35 +6.96%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$17.31 – $25.49

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws Jul 27, 2026

Other filings

SCHEDULE 13G Aug 3, 2026 SCHEDULE 13D Jul 30, 2026 SCHEDULE 13D Jul 30, 2026 4 Jul 29, 2026 4 Jul 29, 2026 4 Jul 29, 2026 SCHEDULE 13D Jul 29, 2026 4 Jul 29, 2026 4 Jul 28, 2026 4 Jul 28, 2026 4 Jul 27, 2026 4 Jul 27, 2026 4 Jul 27, 2026 4 Jul 27, 2026 4 Jul 27, 2026 4 Jul 27, 2026 4 Jul 27, 2026 S-8 Jul 27, 2026 424B4 Jul 27, 2026 FWP Jul 24, 2026 EFFECT Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 3 Jul 23, 2026 S-1MEF Jul 23, 2026 CERT Jul 22, 2026 8-A12B Jul 21, 2026 S-1/A Jul 20, 2026 S-1/A Jul 10, 2026 S-1 Jul 2, 2026